Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

2.

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study.

Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.

Alzheimers Res Ther. 2018 Aug 23;10(1):85. doi: 10.1186/s13195-018-0415-6.

3.

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.

Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Höglund K, Andreasson U, Wetterberg H, Börjesson-Hanson A, Blennow K, Skoog I.

Neurology. 2018 May 8;90(19):e1682-e1691. doi: 10.1212/WNL.0000000000005476. Epub 2018 Apr 13.

4.

Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.

Skoog I, Kern S, Zetterberg H, Östling S, Börjesson-Hanson A, Guo X, Blennow K.

J Alzheimers Dis. 2018;62(4):1877-1886. doi: 10.3233/JAD-170950.

5.

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.

Landen JW, Andreasen N, Cronenberger CL, Schwartz PF, Börjesson-Hanson A, Östlund H, Sattler CA, Binneman B, Bednar MM.

Alzheimers Dement (N Y). 2017 Jun 8;3(3):393-401. doi: 10.1016/j.trci.2017.05.003. eCollection 2017 Sep.

6.

Decreasing prevalence of dementia in 85-year olds examined 22 years apart: the influence of education and stroke.

Skoog I, Börjesson-Hanson A, Kern S, Johansson L, Falk H, Sigström R, Östling S.

Sci Rep. 2017 Jul 21;7(1):6136. doi: 10.1038/s41598-017-05022-8.

7.

Multi-infarct dementia of Swedish type is caused by a 3'UTR mutation of COL4A1.

Siitonen M, Börjesson-Hanson A, Pöyhönen M, Ora A, Pasanen P, Bras J, Kern S, Kern J, Andersen O, Stanescu H, Kleta R, Baumann M, Kalaria R, Kalimo H, Singleton A, Hardy J, Viitanen M, Myllykangas L, Guerreiro R.

Brain. 2017 May 1;140(5):e29. doi: 10.1093/brain/awx062. No abstract available.

PMID:
28369186
8.

A Longitudinal Study of the Mini-Mental State Examination in Late Nonagenarians and Its Relationship with Dementia, Mortality, and Education.

Skoog J, Backman K, Ribbe M, Falk H, Gudmundsson P, Thorvaldsson V, Borjesson-Hanson A, Ostling S, Johansson B, Skoog I.

J Am Geriatr Soc. 2017 Jun;65(6):1296-1300. doi: 10.1111/jgs.14871. Epub 2017 Mar 21.

PMID:
28323333
9.

Author response: Calcium supplementation and risk of dementia in women with cerebrovascular disease.

Kern S, Kern J, Blennow K, Zetterberg H, Waern M, Guo X, Börjesson-Hanson A, Skoog I, Östling S.

Neurology. 2017 Feb 21;88(8):813. doi: 10.1212/WNL.0000000000003646. No abstract available.

PMID:
28220015
10.

Calcium supplementation and risk of dementia in women with cerebrovascular disease.

Kern J, Kern S, Blennow K, Zetterberg H, Waern M, Guo X, Börjesson-Hanson A, Skoog I, Östling S.

Neurology. 2016 Oct 18;87(16):1674-1680. Epub 2016 Aug 17.

11.

DSM-IV and DSM-5 Prevalence of Social Anxiety Disorder in a Population Sample of Older People.

Karlsson B, Sigström R, Östling S, Waern M, Börjesson-Hanson A, Skoog I.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1237-1245. doi: 10.1016/j.jagp.2016.07.023. Epub 2016 Aug 3.

PMID:
27720603
12.

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.

Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.

BMJ Open. 2016 Jul 19;6(7):e011584. doi: 10.1136/bmjopen-2016-011584.

13.

Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years.

Bjerke M, Kern S, Blennow K, Zetterberg H, Waern M, Börjesson-Hanson A, Östling S, Kern J, Skoog I.

J Alzheimers Dis. 2016;49(3):733-41. doi: 10.3233/JAD-150525.

PMID:
26484922
14.

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Wallin A, Nordlund A, Jonsson M, Lind K, Edman Å, Göthlin M, Stålhammar J, Eckerström M, Kern S, Börjesson-Hanson A, Carlsson M, Olsson E, Zetterberg H, Blennow K, Svensson J, Öhrfelt A, Bjerke M, Rolstad S, Eckerström C.

J Cereb Blood Flow Metab. 2016 Jan;36(1):114-31. Review.

15.

Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases.

Craggs L, Taylor J, Slade JY, Chen A, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Viitanen M, Kalimo H, Deramecourt V, Oakley AE, Kalaria RN.

Neuropathol Appl Neurobiol. 2016 Feb;42(2):194-209. doi: 10.1111/nan.12248. Epub 2015 Jun 17.

16.

A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.

Skoog I, Waern M, Duberstein P, Blennow K, Zetterberg H, Börjesson-Hanson A, Östling S, Guo X, Kern J, Gustafson D, Gudmundsson P, Marlow T, Kern S.

Biol Psychiatry. 2015 Nov 15;78(10):730-6. doi: 10.1016/j.biopsych.2015.01.006. Epub 2015 Jan 29.

PMID:
25708227
17.

The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth.

Kern S, Mehlig K, Kern J, Zetterberg H, Thelle D, Skoog I, Lissner L, Blennow K, Börjesson-Hanson A.

Am J Epidemiol. 2015 Feb 1;181(3):214-7. doi: 10.1093/aje/kwu442. Epub 2015 Jan 21. No abstract available.

PMID:
25609095
18.

Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly.

Gislason TB, Östling S, Börjesson-Hanson A, Sjögren M, Simoni M, Pantoni L, Skoog I.

Alzheimers Dement. 2015 Apr;11(4):425-33. doi: 10.1016/j.jalz.2014.03.002. Epub 2014 Jun 18.

PMID:
24954370
19.

Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.

Kern S, Skoog I, Börjesson-Hanson A, Blennow K, Zetterberg H, Ostling S, Kern J, Gudmundsson P, Marlow T, Rosengren L, Waern M.

Brain Behav Immun. 2014 Oct;41:55-8. doi: 10.1016/j.bbi.2014.05.006. Epub 2014 May 20.

PMID:
24858658
20.

Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.

Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, Borjesson-Hanson A, Uitti RJ, Ross OA, Stoessl AJ, Rademakers R, Josephs KA, Dickson DW, Broderick D, Wszolek ZK.

Parkinsonism Relat Disord. 2013 Oct;19(10):869-77. doi: 10.1016/j.parkreldis.2013.05.013. Epub 2013 Jun 17.

21.

Different stages of white matter changes in the original HDLS family revealed by advanced MRI techniques.

Sundal C, Jönsson L, Ljungberg M, Zhong J, Tian W, Zhu T, Linden T, Börjesson-Hanson A, Andersen O, Ekholm S.

J Neuroimaging. 2014 Sep-Oct;24(5):444-52. doi: 10.1111/jon.12037. Epub 2013 Jun 10.

PMID:
23751174
22.

Prevalence of cardiovascular disorders and risk factors in two 75-year-old birth cohorts examined in 1976-1977 and 2005-2006.

Zhi X, Joas E, Waern M, Östling S, Börjesson-Hanson A, Skoog I.

Aging Clin Exp Res. 2013 Aug;25(4):377-83. doi: 10.1007/s40520-013-0058-1. Epub 2013 Jun 4.

PMID:
23740599
23.

Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years.

Kern S, Skoog I, Börjesson-Hanson A, Blennow K, Zetterberg H, Östling S, Kern J, Gudmundsson P, Marlow T, Rosengren L, Waern M.

Brain Behav Immun. 2013 Aug;32:153-8. doi: 10.1016/j.bbi.2013.03.011. Epub 2013 Apr 9. Retraction in: Brain Behav Immun. 2014 Feb;36:216.

PMID:
23583855
24.

Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases.

Craggs LJ, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Andersen O, Viitanen M, Kalimo H, McLean CA, Slade JY, Hall RA, Oakley AE, Yamamoto Y, Deramecourt V, Kalaria RN.

Brain Pathol. 2013 Sep;23(5):547-57. doi: 10.1111/bpa.12041. Epub 2013 Mar 8.

PMID:
23387519
25.

Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds.

Fässberg MM, Ostling S, Börjesson-Hanson A, Skoog I, Wærn M.

BMJ Open. 2013 Feb 1;3(2). pii: e002260. doi: 10.1136/bmjopen-2012-002260. Print 2013.

26.

A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.

van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Bäumer V, Maes G, Corsmit E, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Pimentel J, Nacmias B, Bagnoli S, Sorbi S, Graff C, Chiang HH, Westerlund M, Sanchez-Valle R, Llado A, Gelpi E, Santana I, Almeida MR, Santiago B, Frisoni G, Zanetti O, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schöls L, Heneka MT, Jessen F, Matej R, Parobkova E, Kovacs GG, Ströbel T, Sarafov S, Tournev I, Jordanova A, Danek A, Arzberger T, Fabrizi GM, Testi S, Salmon E, Santens P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Philtjens S, Sleegers K, Bäumer V, Maes G, Corsmit E, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Philtjens S, Theuns J, Sleegers K, Bäumer V, Maes G, Cruts M, Van Broeckhoven C, Engelborghs S, De Deyn PP, Cras P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenbulcke M, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Firmo C, Pimentel J, Sanchez-Valle R, Llado A, Antonell A, Molinuevo J, Gelpi E, Graff C, Chiang HH, Westerlund M, Graff C, Kinhult Ståhlbom A, Thonberg H, Nennesmo I, Börjesson-Hanson A, Nacmias B, Bagnoli S, Sorbi S, Bessi V, Piaceri I, Santana I, Santiago B, Santana I, Helena Ribeiro M, Rosário Almeida M, Oliveira C, Massano J, Garret C, Pires P, Frisoni G, Zanetti O, Bonvicini C, Sarafov S, Tournev I, Jordanova A, Tournev I, Kovacs GG, Ströbel T, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, Jessen F, Matej R, Parobkova E, Danel A, Arzberger T, Maria Fabrizi G, Testi S, Ferrari S, Cavallaro T, Salmon E, Santens P, Cras P; European Early-Onset Dementia Consortium.

Hum Mutat. 2013 Feb;34(2):363-73. doi: 10.1002/humu.22244. Epub 2013 Jan 4.

27.

Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.

Kern S, Skoog I, Ostling S, Kern J, Börjesson-Hanson A.

BMJ Open. 2012 Oct 3;2(5). pii: e001288. doi: 10.1136/bmjopen-2012-001288. Print 2012.

28.

MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK.

Neurology. 2012 Aug 7;79(6):566-74. doi: 10.1212/WNL.0b013e318263575a. Epub 2012 Jul 25.

29.

A population-based study on dementia and stroke in 97 year olds.

Andersson M, Guo X, Börjesson-Hanson A, Liebetrau M, Östling S, Skoog I.

Age Ageing. 2012 Jul;41(4):529-33. doi: 10.1093/ageing/afs040. Epub 2012 Mar 19.

PMID:
22431153
30.

Update of the original HDLS kindred: divergent clinical courses.

Sundal C, Ekholm S, Nordborg C, Jönsson L, Börjesson-Hanson A, Lindén T, Zetterberg H, Viitanen M, Andersen O.

Acta Neurol Scand. 2012 Jul;126(1):67-75. doi: 10.1111/j.1600-0404.2011.01624.x. Epub 2011 Nov 18.

PMID:
22098561
31.

Nonlinear blood pressure effects on cognition in old age: separating between-person and within-person associations.

Thorvaldsson V, Skoog I, Hofer SM, Börjesson-Hanson A, Ostling S, Sacuiu S, Johansson B.

Psychol Aging. 2012 Jun;27(2):375-83. doi: 10.1037/a0025631. Epub 2011 Oct 10.

32.

Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.

Lesén E, Carlsten A, Skoog I, Waern M, Petzold M, Börjesson-Hanson A.

Int Psychogeriatr. 2011 Oct;23(8):1270-7. doi: 10.1017/S1041610211000524. Epub 2011 Mar 28.

PMID:
21447258
33.

A population-based study on the influence of brain atrophy on 20-year survival after age 85.

Olesen PJ, Guo X, Gustafson D, Börjesson-Hanson A, Sacuíu S, Eckerström C, Bigler ED, Skoog I.

Neurology. 2011 Mar 8;76(10):879-86. doi: 10.1212/WNL.0b013e31820f2e26.

34.

Onset and rate of cognitive change before dementia diagnosis: findings from two Swedish population-based longitudinal studies.

Thorvaldsson V, Macdonald SW, Fratiglioni L, Winblad B, Kivipelto M, Laukka EJ, Skoog I, Sacuiu S, Guo X, Ostling S, Börjesson-Hanson A, Gustafson D, Johansson B, Bäckman L.

J Int Neuropsychol Soc. 2011 Jan;17(1):154-62. doi: 10.1017/S1355617710001372. Epub 2010 Nov 17.

PMID:
21083966
35.

One-month prevalence of mental disorders in a population sample of 95-year olds.

Börjesson-Hanson A, Waern M, Ostling S, Gustafson D, Skoog I.

Am J Geriatr Psychiatry. 2011 Mar;19(3):284-91. doi: 10.1097/JGP.0b013e3181e70d09.

PMID:
20808125
36.

Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia.

Ostling S, Gustafson D, Blennow K, Börjesson-Hanson A, Waern M.

J Geriatr Psychiatry Neurol. 2011 Mar;24(1):3-8. doi: 10.1177/0891988710373596. Epub 2010 Jul 2.

PMID:
20601646
37.

Diagnostic criteria influence dementia prevalence.

Wancata J, Börjesson-Hanson A, Ostling S, Sjögren K, Skoog I.

Am J Geriatr Psychiatry. 2007 Dec;15(12):1034-45.

PMID:
18056822
38.

Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds.

Ostling S, Börjesson-Hanson A, Skoog I.

Am J Geriatr Psychiatry. 2007 Dec;15(12):999-1004.

PMID:
18056818
39.

Five-year mortality in relation to dementia and cognitive function in 95-year-olds.

Börjesson-Hanson A, Gustafson D, Skoog I.

Neurology. 2007 Nov 27;69(22):2069-75.

PMID:
18040013
40.

Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL.

Low WC, Junna M, Börjesson-Hanson A, Morris CM, Moss TH, Stevens DL, St Clair D, Mizuno T, Zhang WW, Mykkänen K, Wahlstrom J, Andersen O, Kalimo H, Viitanen M, Kalaria RN.

Brain. 2007 Feb;130(Pt 2):357-67.

PMID:
17235124
41.

Cerebral arteriolar pathology in a 32-year-old patient with CADASIL.

Miao Q, Kalimo H, Bogdanovic N, Kostulas K, Börjesson-Hanson A, Viitanen M.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):455-8. No abstract available.

PMID:
16866991
42.

The prevalence of dementia in 95 year olds.

Börjesson-Hanson A, Edin E, Gislason T, Skoog I.

Neurology. 2004 Dec 28;63(12):2436-8.

PMID:
15623723

Supplemental Content

Loading ...
Support Center